ChitogenX completes opening phases of rotator cuff clinical trial

Mugglehead
By Joseph MortonNov 9, 2022, 11:16 pm211 pts
ChitogenX (CSE:CHGX) (OTCQB:CHNXF) finished its Phase I/II rotator cuff tear repair clinical trial. The U.S. Phase I/II clinical trail is a blinded, randomized controlled study looking into the safety of ORTHO-R for rotator cuff tear repair, compared with standard of care for 78 patients at ten clinical sites…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Former Canadian senator assisting First Nation with cannabis regulations 69

Knocking Over the Glasses 62

Texas Hemp Advocates Nearing 150,000 Signatures Urging Gov. Abbott to Veto SB 3 56

Federal Bill Would ‘Effectively’ Ban All Consumable Hemp Products—’Including CBD’—Congressional Researchers Say 47

Nevada opens foster parenting to those with cannabis records 36

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.